Market Place
Sourcing Support
Gilead To Present HIV Research Progress At AIDS 2024
16 Jul 2024 //
BUSINESSWIRE
ViiV Healthcare To Present Dovato Vs Biktarvy Trial Data At AIDS 2024
15 Jul 2024 //
BUSINESSWIRE
Gilead`s long-acting HIV drug superior to daily pill Truvada in study
21 Jun 2024 //
REUTERS
Gilead, US square off in billion-dollar HIV drug patent trial
03 May 2023 //
REUTERS
Gilead caused injuries while waiting to develop safer HIV drugs,lawsuit claims
07 Apr 2023 //
FIERCE PHARMA
Hagens Berman Sobol , Hilliard Announce a Class Action Antiretroviral Drugs
28 Dec 2022 //
PR NEWSWIRE
Federal claims court rules in favor of Gilead in CDC Truvada patent case
01 Dec 2022 //
ENDPTS
Lupin gets USFDA nod for HIV drug under PEPFAR
30 Jun 2021 //
ECONOMIC TIMES
Study shows newer anti-HIV drugs safest, most effective during pregnancy
12 Mar 2020 //
PHARMABIZ
Gilead`s Descovy not worth the higher price
10 Mar 2020 //
FIERCE PHARMA
Gilead, seeking HIV patent extension, faces `gamesmanship` claims from patients
07 Dec 2019 //
FIERCE PHARMA
Gilead’s converting Truvada PrEP users to Descovy faster than expected
03 Dec 2019 //
FIERCE PHARMA
PvPI study reveals major suspected ADRs in anti-retroviral drugs
07 Aug 2019 //
PHARMABIZ
Laurus Labs gets USFDA nod for HIV drug
09 Feb 2019 //
ECONOMIC TIMES
Indonesia seeks to reassure HIV patients over drug supplies
14 Jan 2019 //
REUTERS
Viread® (tenofovir disoproxil fumarate) : Gilead Sciences vs. Laurus Labs
12 Nov 2018 //
PATENT LITIGATION
Rare HIV PrEP Failure Reported in San Francisco
12 Oct 2018 //
MEDPAGE TODAY
Is Gilead Poised for a Comeback?
07 Jul 2018 //
BIOSPACE
NPPA fixes prices of 22 drug formulations
13 Jun 2018 //
ECONOMIC TIMES
ContraVir`s Announces TXL™ Has Been Granted Orphan Drug Designation
22 Feb 2018 //
PRESS RELEASE
GeoVax draws a bead on hep B with therapeutic vaccine deal
19 Jan 2017 //
FIERCE BIOTECH
The Glaxo-Gilead HIV Battle Could Be Epic
28 Dec 2016 //
SEEKING ALPHA
ContraVir expands phase 2a trial of tenofovir exalidex
20 Dec 2016 //
PHARMABIZ
Gilead asks FDA to Expand Exclusivity for a Key HIV Drug
21 Oct 2016 //
STAT
Indian Generic Manufacturer Cipla Targeting US HIV Market
31 Mar 2016 //
TWOFOUR INSIGHT
New drugs from Abbvie, Gilead, Intercept and Merck forecast
03 Feb 2016 //
CPHIONLINE
Gilead Faces Lawsuits over AIDS Drug Patents, Threats of Lawsuits for Hep C
29 Jan 2016 //
BIOSPACE
Cipla ready to launch low dose HIV drug `Efavirenz`
01 Dec 2015 //
ECONOMIC TIMES
J&J buys firm seeking hepatitis B cure
05 Nov 2015 //
PM LIVE
Gilead takes a $125M FDA shortcut with its latest HIV combo
03 Jul 2015 //
FIERCE BIOTECH
Law enforcement makes another illegal pharma supply chain bust; 2nd in U.S. in 8 days
26 May 2015 //
FIERCE PHARMA MANUFACTURING
Gilead`s low-dose, high-impact HIV drug heads to the FDA
09 Apr 2015 //
SAN FRANSISCO BUSINESS TIMES
Which Pharma Needs Its Cash Cow Most? It`s Not Just About Numbers
05 Mar 2015 //
FIERCE PHARMA
Gilead’s Pill Can Stop HIV. So Why Does Almost Nobody Take It?
18 Feb 2015 //
BLOOMBERG BUSINESS
A Failed Trial in Africa Raises Questions About How to Test H.I.V. Drugs
04 Feb 2015 //
THE NEW YORK TIMES
